01280nas a2200457   4500000000100000000000100001000000100002008004100003653001100044653000900055653001100064653004000075653000900115653002200124653001600146653002900162653002300191653001700214653003700231653002300268653003200291653004200323653001600365653005600381653001900437653001300456653002900469653001700498100001300515700001300528700001700541700001600558700001700574700002300591700001200614700002100626245012200647250001500769490000700784020003100791       2024                            d10aHumans10aMale10aFemale10a*Dementia/drug therapy/epidemiology10aAged10aAged, 80 and over10aMiddle Aged10aNetherlands/epidemiology10aDatabases, Factual10aTime Factors10aNootropic Agents/therapeutic use10aSpain/epidemiology10aUnited Kingdom/epidemiology10aPractice Patterns, Physicians'/trends10aAge Factors10aDrug Utilization/trends/statistics & numerical data10aCohort Studies10adementia10adrug utilization studies10aOlder people1 aC. Reyes1 aD. Newby1 aB. Raventós1 aK. Verhamme1 aM. Mosseveld1 aD. Prieto-Alhambra1 aE. Burn1 aT. Duarte-Salles00aTrends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study  a2024/05/240 v53  a0002-0729 (Print)0002-0729